San Donato Hospital
| Italia | Turchia | Austria | |
| Terapia con protoni | da $70,000 | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | da $18,000 | da $9,500 | da $22,000 |
| Resezione gastrica | da $18,000 | da $16,470 | da $22,000 |
| Radioterapia per il cancro allo stomaco | da $14,500 | da $3,250 | da $6,870 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $22,000 | da $3,300 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro gastrico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro gastrico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro gastrico.
Dr. Antonio Braun has performed over 12,000 gastrointestinal interventions at Maria Cecilia Hospital. He is a board-certified general surgeon specializing in bariatric and digestive surgery. He completed a two-year training internship at Johns Hopkins University. Dr. Braun uses laparoscopic techniques to improve patient recovery and safety.
Dirige uno dei Centri ad Alto Volume più riconosciuti d'Italia per la chirurgia esofagea presso l'Ospedale San Raffaele. Il suo reparto gestisce 2.000 casi chirurgici all'anno.
Dr. Marcello Deraco has treated over 1,200 patients with peritoneal cancer. He directs the Peritoneal Surface Malignancies Unit at Maria Cecilia Hospital. Dr. Deraco specializes in cytoreductive surgery and heated chemotherapy. He is a professor of surgery at Milan University.
Il medico è specialista in chirurgia generale con un focus sulle malattie della tiroide e delle paratiroidi, eseguendo oltre 200 interventi chirurgici all'anno utilizzando tecniche minimamente invasive. Inoltre, il medico è esperto nel trattamento laparoscopico delle malattie surrenali. Il medico applica un'ampia esperienza nell'organizzazione del trattamento delle patologie gastrointestinali, inclusi esofago, stomaco, colon, fegato, vie biliari e pancreas, oltre a trattare le malattie della parete addominale e le malattie tumorali complesse.<\/p>
Italy offers world-class stomach cancer care at IRCCS-accredited research hospitals like San Raffaele and Agostino Gemelli. These centers specialize in robotic gastrectomies and multidisciplinary oncology. Leading surgeons perform over 2,000 gastrointestinal procedures annually. This ensures high success rates and surgical precision.
Bookimed Expert Insight: Italian oncology excellence is concentrated in IRCCS-designated facilities that legally must combine patient care with active research. Data shows that specialists like Dr. Antonio Braun have performed over 12,000 gastrointestinal interventions. This volume-to-outcome correlation is vital. Patients should prioritize hospitals in Milan or Rome. These cities house centers with the highest surgical throughput and dedicated gastric research programs.
Patient Consensus: Patients note that the professionalism and equipment in Milanese clinics often exceed standards found elsewhere in Europe. They emphasize the value of having a dedicated international department to navigate the multidisciplinary treatment steps.
Italian oncology centers utilize advanced therapies like Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for complex gastric malignancies. Facilities like San Raffaele also employ the da Vinci robotic system for high-precision gastrectomies with reduced recovery times.
Bookimed Expert Insight: Italian research hospitals like San Raffaele combine clinical care with extensive laboratory research. This integration is why they perform over 52,000 operations annually across multiple specialties. For patients, this high volume translates to doctors who see rare complications more frequently. This usually leads to more personalized treatment plans for advanced-stage cases.
Patient Consensus: Patients emphasize that choosing private clinics helps bypass long wait times often found in public hospitals. They also note the professionalism of Italian staff and recommend arranging language support for smoother communication.
International patients should plan for at least 14 to 21 days in Italy. This timeframe includes surgical hospitalization and mandatory post-operative recovery. Gastrectomy procedures often require 7 to 9 hospital days. Surgeons issue a mandatory Fit to Fly certificate before patients can safely travel home.
Bookimed Expert Insight: While most clinics suggest 14 days, high-volume centers like San Raffaele emphasize that gut recovery varies. Dr. Riccardo Rosati manages over 2,000 yearly surgical cases in the GI department. Data shows that large research hospitals provide more predictable timelines due to extensive experience with 52,000 annual operations.
Patient Consensus: Patients note that Italian medical teams are exceptionally professional and use advanced equipment. It is important to stay near the clinic for at least one week after discharge for follow-up visits.
Medical tourists cannot access cancer treatments through the Italian public system for free. Non-residents must pay full costs for planned therapies. Only foreign nationals with a valid residence permit can register for the National Health Service (SSN) to access subsidized oncology care.
Bookimed Expert Insight: While Italy is famous for its public care, private departments in major research hospitals like San Raffaele in Milan provide faster access to specialized technology. For example, Dr. Riccardo Rosati leads a department performing 2,000 surgical cases annually, including complex stomach resections. Patients choosing these private tracks bypass the public system's long administrative wait times while utilizing the same top-tier surgeons who also serve the public sector.
Patient Consensus: Patients note that navigating the Italian healthcare system requires precise documentation and significant upfront planning for non-residents. Many emphasize that choosing a facility with a dedicated international department helps manage official paperwork and clinical coordination much more smoothly.
Stomach cancer treatment in Italy centres on multidisciplinary care at high-volume research hospitals. Primary options include gastrectomy with D2 lymph node dissection, perioperative chemotherapy, and robotic-assisted surgery. Specialised centres like San Raffaele also offer immunotherapy and heated chemotherapy for complex cases.
Bookimed Expert Insight: Italian research hospitals combine high surgical volume with academic research. Data shows San Raffaele performs over 52,000 operations yearly. This scale allows doctors like Dr Marcello Deraco to treat 1,200+ peritoneal cases using HIPEC.
Patient Consensus: Patients note the professionalism of Italian doctors and the availability of equipment in Milan. Many find the care and surgical technology exceeds what they experienced in other European countries.
Robotic surgery for stomach cancer is available in Italy, primarily using the Da Vinci Robotic System. Specialists at IRCCS-accredited research hospitals perform robotic-assisted gastrectomies. These provide precise tumour removal and lymph node dissection. These minimally invasive procedures typically lead to faster recovery times and less post-operative pain.
Bookimed Expert Insight: Italy’s strength lies in combining robotic surgery with specialised intraperitoneal chemotherapy. Doctors like Prof. Marcello Deraco have treated over 1,200 patients using CRS and HIPEC. This integrated approach is often more critical for stomach cancer outcomes than the robotic platform alone.
Patient Consensus: Patients note the professionalism and modern equipment in Milan are among the best in Europe. They often highlight the high level of staff care during recovery from complex stomach cancer surgeries.
Italy offers specialised stomach cancer treatment through research hospitals performing thousands of oncology procedures annually. Centres like San Raffaele use robotic gastrectomies and treatments such as HIPEC for advanced stages. Most major Italian facilities hold IRCCS (Scientific Institute for Research, Hospitalisation and Healthcare) accreditation for evidence-based clinical care.
Bookimed Expert Insight: Many European centres offer standard oncology. However, Italian hospitals specifically focus on advanced peritoneal spread. Prof. Marcello Deraco at Maria Cecilia Hospital trained at leading UK and USA institutes. He specialises in HIPEC and PIPAC. This makes Italy a primary choice for stage 4 patients with peritoneal involvement.
Patient Consensus: Patients in Italy highlight the high-quality equipment and the professionalism of international departments. One noted that care at San Raffaele is among the best in Europe. They praised the support provided during complex gastric cancer treatment.
International patients can access stomach cancer clinical trials in Italy through accredited research hospitals called IRCCS. These centres, such as San Raffaele in Milan, run trials on metastatic gastric cancer and immunotherapy. Participation depends on meeting strict medical and genetic inclusion criteria.
Bookimed Expert Insight: Italian research centres like San Raffaele serve 300,000 patients annually. They operate as major European research hubs. Leading specialists often have international backgrounds. For example, Dr Antonio Braun trained at Johns Hopkins. This global perspective makes these centres more accessible to international patients seeking specialised protocols.
Patient Consensus: Patients note the medical equipment and professionalism in Milan are among the best in Europe. They often find that care for stomach cancer exceeds experiences in other major medical hubs.
Patients can get a second opinion in Italy by booking a consultation at IRCCS-accredited research hospitals. Specialists provide remote or in-person reviews of pathology slides and imaging. This process confirms staging and treatment plans using techniques like Da Vinci robotic gastrectomy or HIPEC.
Bookimed Expert Insight: Italian IRCCS centres combine clinical care with active research. Dr Michele Reni at San Raffaele chairs clinical trials for gastro-oesophageal cancers. An opinion here often provides access to emerging treatments or trials. These may not be standard in Australian practice yet. This can be vital for stage 3 or 4 cases.
Patient Consensus: Patients note Italian staff are highly professional. They recommend sending a single digital packet of pathology and imaging reports. This helps speed up the process. Getting a multidisciplinary review from a team in Milan is often described as the best approach.
Patients should plan for 14 to 21 days in Italy for stomach cancer surgery. This includes 7 to 9 hospital nights and extra days for recovery. Chemotherapy or immunotherapy involves shorter, repeated visits rather than one long stay.
Bookimed Expert Insight: Surgery requires a 3-week stay. However, Milan's research hospitals offer PET/CT and molecular imaging protocols. These allow for rapid staging and therapy response assessment. This efficiency helps patients start targeted treatments like Keytruda or PIPAC sooner than many Australian public systems.
Patient Consensus: Patients note that Italian hospitals like San Raffaele offer some of the best care in Europe. They appreciate the professionalism of international departments. They also value access to modern surgical equipment during their recovery in Milan.